- Home
- ARQQ vs CCEL Comparison
ARQQ vs CCEL Comparison
Compare ARQQ & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- CCEL
- Stock Information
- Founded
- ARQQ 2017
- CCEL 1989
- Country
- ARQQ United Kingdom
- CCEL United States
- Employees
- ARQQ N/A
- CCEL N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- CCEL Managed Health Care
- Sector
- ARQQ Technology
- CCEL Health Care
- Exchange
- ARQQ Nasdaq
- CCEL Nasdaq
- Market Cap
- ARQQ 50.0M
- CCEL 53.9M
- IPO Year
- ARQQ N/A
- CCEL 1997
- Fundamental
- Price
- ARQQ $3.87
- CCEL $6.48
- Analyst Decision
- ARQQ Strong Buy
- CCEL
- Analyst Count
- ARQQ 1
- CCEL 0
- Target Price
- ARQQ $50.00
- CCEL N/A
- AVG Volume (30 Days)
- ARQQ 111.5K
- CCEL 3.6K
- Earning Date
- ARQQ 11-19-2024
- CCEL 10-18-2024
- Dividend Yield
- ARQQ N/A
- CCEL N/A
- EPS Growth
- ARQQ N/A
- CCEL N/A
- EPS
- ARQQ N/A
- CCEL N/A
- Revenue
- ARQQ $740,000.00
- CCEL $31,641,636.00
- Revenue This Year
- ARQQ $341.56
- CCEL $3.70
- Revenue Next Year
- ARQQ $274.91
- CCEL $10.57
- P/E Ratio
- ARQQ N/A
- CCEL N/A
- Revenue Growth
- ARQQ N/A
- CCEL 1.93
- 52 Week Low
- ARQQ $3.72
- CCEL $3.67
- 52 Week High
- ARQQ $23.00
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- ARQQ 32.80
- CCEL 50.32
- Support Level
- ARQQ $3.75
- CCEL $6.29
- Resistance Level
- ARQQ $6.00
- CCEL $6.80
- Average True Range (ATR)
- ARQQ 0.69
- CCEL 0.29
- MACD
- ARQQ -0.09
- CCEL 0.03
- Stochastic Oscillator
- ARQQ 5.70
- CCEL 31.07
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology which makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. Arqit delivers its symmetric key agreement technology via its QuantumCloud. Its product, QuantumCloud, enables any device to download a lightweight software agent, which can create keys in partnership with any other device. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. Key revenue comes from the UK.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.